Skip to main content

News & Updates

news and updates icon

News & Updates

USPTO Invention-Con on the Road

Invention-Con is the USPTO’s annual conference for independent inventors, entrepreneurs, and small-business owners whose success depends on guarding their creative work. Tailored for the independent inventor community, this free marquee event brings inspiration and resources directly to you. Connect with fellow…

Read More

Celebrating innovative, creative and enterprising changemakers around the world

Every April 26, we celebrate World Intellectual Property Day to learn about the role that IP rights play in encouraging innovation and creativity. In 2024 World IP Day celebrates changemakers worldwide who are driving the innovation and creativity needed to…

Read More

Toddler Dining Mat Patent Dispute Highlights Importance of Candor in Patent Litigation

Luv N’ Care, Ltd. v. Laurain Authored by: Jeremy J. Gustrowsky A recent decision from the Federal Circuit sheds light on the high stakes of honesty and fair play in patent lawsuits, especially when it comes to innovative products for…

Read More

Court Affirms Obviousness of Rifaximin Patents, Clarifies ANDA Approval Timing

Salix Pharms., Ltd. v. Norwich Pharms. Inc Authored by: Jeremy J. Gustrowsky A recent appellate decision sheds light on the complex interplay between pharmaceutical patents, generic drug approvals, and the standards for proving a patent is “obvious” in light of…

Read More

Remote Medical Imaging Patents Found Too Abstract for Protection

AI Visualize, Inc. v. Nuance Commc’ns, Inc. Authored by: Jeremy J. Gustrowsky A recent decision from the Federal Circuit highlights the ongoing challenges of patenting software-based inventions, especially those involving data processing and remote access. In this case, AI Visualize,…

Read More

When “Known” Isn’t Enough: Federal Circuit Clarifies Motivation to Combine in Patent Obviousness

Virtek Vision Int’l ULC v. Assembly Guidance Sys Authored by: Jeremy J. Gustrowsky A recent Federal Circuit decision highlights a key principle in patent law: just because two technical approaches are “known” doesn’t mean it’s obvious to combine them. The…

Read More

Jury Instruction Error on Patent Obviousness Triggers New Trial in Tamper-Resistant Container Dispute

Inline Plastics Corp. v. Lacerta Grp., LLC Authored by: Jeremy J. Gustrowsky A recent decision highlights the importance of proper jury instructions in patent cases, especially when it comes to evaluating whether an invention is “obvious” in light of earlier…

Read More

The use of AI and patented inventions.

Mike Morris quoted in the article, When is an AI-assisted invention eligible for a patent? To read the full article, please visit The Indiana Lawyer.

Read More

Reclaiming the web: Three ways to combat counterfeit websites

In the latest issue of The Indiana Lawyer, Blake Hartz and Shane Moreillon explore three options to shut down counterfeit websites impersonating your client or their products. To read the full article, please visit The Indiana Lawyer.

Read More

Medical Device Importation for FDA Approval Falls Under Patent Safe Harbor

Edwards Lifesciences Corp. v. Meril Life Scis. Priv. Ltd Authored by: Jeremy J. Gustrowsky A recent decision clarified how the “safe harbor” provision in U.S. patent law protects companies when they import medical devices for activities related to FDA approval.…

Read More

No Contradiction, No Problem: Federal Circuit Clarifies Patent Claim Language on Lithium-Ion Batteries

Maxell, Ltd. v. Amperex Tech. Ltd Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit provided important guidance on how patent claims should be interpreted when it comes to potentially conflicting language. The case involved Maxell, Ltd.,…

Read More

Patent Claims on Targeted Online Ads Face Mixed Results in Court

Chewy, Inc. v. IBM Authored by: Jeremy J. Gustrowsky A recent decision from the Federal Circuit highlights the challenges of enforcing patents related to online advertising and targeted marketing. The dispute centered on two patents owned by IBM: U.S. Patent…

Read More